【结 构 式】 |
【药物名称】Flindokalner, BMS-204352, MaxiPost 【化学名称】(+)-3(S)-(5-Chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-2,3-dihydro-1H-indol-2-one 【CA登记号】187523-35-9, 187523-36-0 ((R)-isomer), 183720-28-7 (racemate) 【 分 子 式 】C16H10ClF4NO2 【 分 子 量 】359.7102 |
【开发单位】Bristol-Myers Squibb (Originator) 【药理作用】Cerebrovascular Diseases, Treatment of, NEUROLOGIC DRUGS, Stroke, Treatment of, Large Conductance BK(Ca) Channel Activators, Voltage-Gated KCNQ Channel Activators |
合成路线1
3-(Trifluoromethyl)aniline (I) was protected as the tert-butyl carbamate (II) by treatment with Boc2O at 80 C. Lithiation of (II) with sec-butyllithium at -78 C, followed by condensation with diethyl oxalate afforded keto ester (III). Subsequent acid hydrolysis of the Boc group of (III) with concomitant cyclization gave rise to 6-(trifluoromethyl)isatin (IV). Addition of Grignard reagent (V) to (IV) produced the 3-hydroxy-3-aryloxindole (VI). Conversion of (VI) to the corresponding 3-fluoro oxindole was then effected by treatment with diethylaminosulfur trifluoride at low temperature. Finally, optical resolution by means of chiral HPLC furnished the title (S)-enantiomer.
【1】 Hewawasam, P.; et al.; The synthesis and characterization of BMS-204352 (MaxiPost) and related 3-fluorooxindoles as openers of maxi-K potassium channels. Bioorg Med Chem Lett 2002, 12, 7, 1023. |
【2】 Starrett, J.E. Jr.; Hewawasam, P.; Ortiz, A.A.; et al.; Synthesis, pharmacokinetic analysis and MCAO stroke activity of the maxi-K opener BMS-204352. Pottasium Channels: Struct Funct Ther Util (March 11 2000, Tahoe City) 2000, Abst 315. |
【3】 Martín, L.; Castañer, R.M.; Sorbera, L.A.; Castañer, J.; BMS-204352. Drugs Fut 2001, 26, 1, 9. |
【4】 Hewawasam, P.; Meanwell, N.A.; Gribkoff, V.K. (Bristol-Myers Squibb Co.); 3-Substd. oxindole derivs. as potassium channel modulators. CA 2176183; EP 0747354; JP 1996333336; US 5565483; US 5602169 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26347 | 3-(trifluoromethyl)phenylamine; 3-(trifluoromethyl)aniline; 3-aminobenzotrifluoride | 98-16-8 | C7H6F3N | 详情 | 详情 |
(II) | 39335 | tert-butyl 3-(trifluoromethyl)phenylcarbamate | C12H14F3NO2 | 详情 | 详情 | |
(III) | 39336 | ethyl 2-[2-[(tert-butoxycarbonyl)amino]-4-(trifluoromethyl)phenyl]-2-oxoacetate | C16H18F3NO5 | 详情 | 详情 | |
(IV) | 39337 | 6-(trifluoromethyl)-1H-indole-2,3-dione | C9H4F3NO2 | 详情 | 详情 | |
(V) | 39338 | bromo(5-chloro-2-methoxyphenyl)magnesium | C7H6BrClMgO | 详情 | 详情 | |
(VI) | 39339 | 3-(5-chloro-2-methoxyphenyl)-3-hydroxy-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one | C16H11ClF3NO3 | 详情 | 详情 |
合成路线2
A chiral process for the synthesis of the title compound was later reported. Chlorination of 2-methoxyphenylacetic acid (VII) with sulfuryl chloride gave (VIII), which was further converted to the corresponding methyl ester (IX) by treatment with dimethyl sulfate and K2CO3. Conversion of (IX) to the lithium enolate with lithium hexamethyldisilazide, followed by condensation with aryl fluoride (X) yielded the diarylacetic ester (XI). This was reacted with N-fluoro-bis(phenylsulfonyl)amine to provide fluoro ester (XII). Basic hydrolysis afforded the racemic carboxylic acid (XIII), which was resolved via conversion to the diastereoisomeric salts with (S)-alpha-methylbenzylamine. Reduction of the nitro group from the desired (S)-enantiomer (XIV), and subsequent acidic treatment then produced the title oxindole derivative.
【1】 Hewawasam, P.; et al.; The synthesis and characterization of BMS-204352 (MaxiPost) and related 3-fluorooxindoles as openers of maxi-K potassium channels. Bioorg Med Chem Lett 2002, 12, 7, 1023. |
【2】 Martín, L.; Castañer, R.M.; Sorbera, L.A.; Castañer, J.; BMS-204352. Drugs Fut 2001, 26, 1, 9. |
【3】 Thottathil, J.K.; Pendri, Y.R.; Martinez, E.J.; Hewawasam, P. (Bristol-Myers Squibb Co.); Preparation of 3-fluoro oxindole derivs.. WO 9816222 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VII) | 19706 | 2-(2-methoxyphenyl)acetic acid | 93-25-4 | C9H10O3 | 详情 | 详情 |
(VIII) | 39340 | 2-(5-chloro-2-methoxyphenyl)acetic acid | C9H9ClO3 | 详情 | 详情 | |
(IX) | 39341 | methyl 2-(5-chloro-2-methoxyphenyl)acetate | C10H11ClO3 | 详情 | 详情 | |
(X) | 39342 | 1-fluoro-2-nitro-4-(trifluoromethyl)benzene | 367-86-2 | C7H3F4NO2 | 详情 | 详情 |
(XI) | 39343 | methyl 2-(5-chloro-2-methoxyphenyl)-2-[2-nitro-4-(trifluoromethyl)phenyl]acetate | C17H13ClF3NO5 | 详情 | 详情 | |
(XII) | 39344 | methyl 2-(5-chloro-2-methoxyphenyl)-2-fluoro-2-[2-nitro-4-(trifluoromethyl)phenyl]acetate | C17H12ClF4NO5 | 详情 | 详情 | |
(XIII) | 39345 | 2-(5-chloro-2-methoxyphenyl)-2-fluoro-2-[2-nitro-4-(trifluoromethyl)phenyl]acetic acid | C16H10ClF4NO5 | 详情 | 详情 | |
(XIV) | 39346 | (2S)-2-(5-chloro-2-methoxyphenyl)-2-fluoro-2-[2-nitro-4-(trifluoromethyl)phenyl]ethanoic acid | C16H10ClF4NO5 | 详情 | 详情 |
合成路线3
The reaction of 3-(trifluoromethyl)aniline (I) with Boc2O gives the carbamate (II), which is condensed with 14C labeled diethyl oxalate (III) by means of BuLi to yield the ketoester (IV). The cyclization of (IV) by means of refluxing aq. HCl affords the labeled 6-(trifluoromethyl)isatin (V), which is condensed with 5-chloro-2-methoxyphenylmagnesium bromide (VI) to provide the hydroxyketone (VII). The fluorination of (VII) with DAST gives the target compound as a racemic mixture (VIII), which is finally submitted to optical resolution by chiral HPLC.
【1】 Dischino, D.D.; Gribkoff, V.K.; Hewawasam, P.; Luke, G.M.; Rinehart, J.K.; Spears, T.L.; Starrett, J.E. Jr.; Synthesis of 3H and 14C labeled (S)-3-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one, MaxiPost(TM). An agent for post-stroke neuroprotection. J Label Compd Radiopharm 2003, 46, 2, 139. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 26347 | 3-(trifluoromethyl)phenylamine; 3-(trifluoromethyl)aniline; 3-aminobenzotrifluoride | 98-16-8 | C7H6F3N | 详情 | 详情 |
(II) | 39335 | tert-butyl 3-(trifluoromethyl)phenylcarbamate | C12H14F3NO2 | 详情 | 详情 | |
(III) | 17571 | Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate | 95-92-1 | C6H10O4 | 详情 | 详情 |
(III) | 64193 | allyl (2R,3S,4R,5R)-2-[({(2R,3R,4R,5S,6R)-5-{[bis(allyloxy)phosphoryl]oxy}-4-{[(3R)-3-methoxydecyl]oxy}-6-(methoxymethyl)-3-[(Z)-11-octadecenoylamino]tetrahydro-2H-pyran-2-yl}oxy)methyl]-6-{[tert-butyl(dimethyl)silyl]oxy}-4-(decyloxy)-5-[(3-oxotetradecanoyl)amino]tetrahydro-2H-pyran-3-yl carbonate | C82H151N2O18PSi | 详情 | 详情 | |
(IV) | 39336 | ethyl 2-[2-[(tert-butoxycarbonyl)amino]-4-(trifluoromethyl)phenyl]-2-oxoacetate | C16H18F3NO5 | 详情 | 详情 | |
(IV) | 64197 | ethyl 2-[2-[(tert-butoxycarbonyl)amino]-4-(trifluoromethyl)phenyl]-2-oxoacetate | C16H18F3NO5 | 详情 | 详情 | |
(V) | 39337 | 6-(trifluoromethyl)-1H-indole-2,3-dione | C9H4F3NO2 | 详情 | 详情 | |
(V) | 64198 | 6-(trifluoromethyl)-1H-indole-2,3-dione | C9H4F3NO2 | 详情 | 详情 | |
(VI) | 39338 | bromo(5-chloro-2-methoxyphenyl)magnesium | C7H6BrClMgO | 详情 | 详情 | |
(VII) | 39339 | 3-(5-chloro-2-methoxyphenyl)-3-hydroxy-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one | C16H11ClF3NO3 | 详情 | 详情 | |
(VII) | 64199 | 3-(5-chloro-2-methoxyphenyl)-3-hydroxy-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one | C16H11ClF3NO3 | 详情 | 详情 | |
(VIII) | 43889 | 3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one | C16H10ClF4NO2 | 详情 | 详情 | |
(VIII) | 64200 | 3-(5-Chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-2,3-dihydro-1H-indol-2-one | C16H10ClF4NO2 | 详情 | 详情 |
合成路线4
The methylation of the phenolic OH of indanone (I) with tritium labeled methyl iodide and Cs2CO3 gives the methyl ether (II). The fluorination of the remaining OH of (II) with DAST yields the target compound as a racemic mixture, that is optically resolved by chiral HPLC.
【1】 Dischino, D.D.; Gribkoff, V.K.; Hewawasam, P.; Luke, G.M.; Rinehart, J.K.; Spears, T.L.; Starrett, J.E. Jr.; Synthesis of 3H and 14C labeled (S)-3-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one, MaxiPost(TM). An agent for post-stroke neuroprotection. J Label Compd Radiopharm 2003, 46, 2, 139. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 64259 | 3-(5-chloro-2-hydroxyphenyl)-3-hydroxy-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one | C15H9ClF3NO3 | 详情 | 详情 | |
(II) | 39339 | 3-(5-chloro-2-methoxyphenyl)-3-hydroxy-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one | C16H11ClF3NO3 | 详情 | 详情 | |
(II) | 64260 | 3-(5-chloro-2-methoxyphenyl)-3-hydroxy-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one | C16H11ClF3NO3 | 详情 | 详情 | |
(III) | 43889 | 3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one | C16H10ClF4NO2 | 详情 | 详情 | |
(III) | 64261 | 3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1,3-dihydro-2H-indol-2-one | C16H10ClF4NO2 | 详情 | 详情 |